The global central lab market size, in terms of value, is estimated to be around US$ 2,543.9 million in 2023. During the market forecast period from 2023 to 2033, the overall market is anticipated to expand at a CAGR of 5.8%. By the end of 2033, the net worth of total business by central labs worldwide could reach up to US$ 4,473.5 million.
Central Lab Market Trends
| Report Attribute | Details |
|---|---|
| Central Lab Market Share (2023) | US$ 2,543.9 million |
| Market Anticipated Forecast Value (2033) | US$ 4,473.5 million |
| Market Projected Growth Rate (2023 to 2033) | 5.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to our market survey, the demand for central lab services surged at 4.1% CAGR from 2018 to 2022 with a market valuation of US$ 2,422.7 million. During the evaluation period, the worldwide central lab market was projected to have strong growth potential due to rising pharmaceutical and biotechnology company activities.
| Attributes | Details |
|---|---|
| Central Lab Market Size (2018) | US$ 1,980.8 million |
| Market Size (2022) | US$ 2,422.7 million |
| Market (CAGR 2018 to 2022) | 4.1% |
The importance of central labs surged during the pandemic years as they witnessed tremendous opportunities regarding research and development for curbing COVID-19 spread. Also, central labs were much preferred for genetic sequencing since they have better and more advanced technology, ultimately setting the trend for the future.
The need for central laboratories has increased since pharmaceutical companies always look for methods to lower the cost of medication research and manufacturing. So, giant pharmaceutical businesses are also making significant investments to establish facilities for providing central lab equipment and services in recent years.
To combat the rising burden of many chronic illnesses, several government health institutions have also come forward to encourage entrepreneurs to set up central labs. Throughout the projected period, government support is anticipated to serve as a driving force for clinical central laboratory market expansion.
In light of strict criteria for the standard of lab data in trials, central labs have recently emerged as the best choices for clinical trials. Also, the existence of advanced technologies and the inability of local laboratories to organize necessary tests has surged the demand for central labs in recent years.
Automation of procedures has boosted the central lab output as it requires less human interaction and performs better all around. Additionally, they have increased the scope of their services by integrating technological and software advancements.
Principal Consultant
Clinical trials in any centralized laboratory services industry are one of the most expensive procedures that limit market expansion to certain degrees. Additionally, the necessity for significant capital expenditures to set up and run central lab equipment and services is restricting market expansion.
As central laboratory testing services deal with the healthcare sector, sufficient medical infrastructure remains a crucial challenge for the overall market. Also, regulatory difficulties have hindered the development of clinical central laboratory industry trends.
Owing to numerous clinical testing central labs, the United States has dominated the global market for a very long time. In 2022, the total revenue generated by the market players present in the country was around US$ 1,010.2 million. The United States market is expected to expand at a healthy rate during the forecast period with rising drug research and development activities.
In 2022, Germany contributed roughly US$ 112 million in the total revenue of US$ 456 million generated by central lab services in Europe. An increase in genetic disorders and clinical testing services cases is poised to keep the German market profitable in the coming days. Also, some advanced central labs, including Eurofins in Luxembourg, are expected to keep the central laboratory testing services trends intact.
In the table below, we provide an estimated market share of the performing three countries in different geographical locations. The United States remains the leading market for central laboratory testing services trends. Meanwhile, Germany and Japan lead Europe and Asia markets, respectively, in demand for clinical trials.
| Regional Market Comparison | Global Market Share in Percentage (2023) |
|---|---|
| United States | 51% |
| Germany | 6% |
| Japan | 3% |
The market in the United Kingdom could progress at a higher rate than in Germany. The growing popularity of Alzheimer’s therapeutics services in the country has substantially improved the central lab outsourcing market in recent years. In addition, strengthening the medical tourism sector is projected to drive the market at a higher rate during the forecast years.
China is the leading market for central laboratory testing services in Asia, poised to grow 7.6% through 2033. China is also likely to witness a higher growth rate in demand for lab accessories used in central labs in the next ten years. Also, favorable support from the Chinese government for improving the country's central laboratory services market outlook is expected to drive this trend.
The need for central labs has significantly increased in India with rising government and pharmaceutical company investments in the development of innovative drugs. However, regulatory difficulties and the scarcity of central labs in many emerging and impoverished locations in India are still leading concerns for market growth.
The table below represents the projected growth rates for the expansion of regional markets as per central lab market statistics and forecast. Though Asian countries like China and India are likely to witness higher growth rates, the United Kingdom and Australia are anticipated to experience remarkable growth through 2033.
| Regional Markets | CAGR (2023 to 2033) |
|---|---|
| United Kingdom | 5.1% |
| China | 7.6% |
| India | 6% |
| Australia | 4.9% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The incidence of chronic illnesses, including cancer, Alzheimer's disease, and diabetes, is on the rise and could drive the business of the central labs. This trend demonstrates the rising demand for biomarkers that form the leading service segment and generated almost US$ 772.5 million in 2022.
| Attributes | Details |
|---|---|
| Top Service Type | Biomarker |
| Market Share in 2023 | 39% |
Central labs are primarily located where most clinical studies are carried out, limiting the business opportunities for the central diagnostic laboratories market. So, new drug discovery is the primary activity in central labs, resulting in the biotechnology sector being the dominant end-user segment for the overall market. However, the rising need for novel medications and vaccines after the pandemic has strengthened the market position of the pharmaceutical segment.
| Attributes | Details |
|---|---|
| Top End User | Biotechnology |
| Market Share in 2023 | 42% |
Multinational corporations are noticeably at the forefront of the adoption of services provided by central labs because of the many advantages they provide. Furthermore, to enhance the services provided by the central lab business, global market players are adopting collaborations and agreements as essential development tactics.
Emmes is a renowned organization that provides full-service clinical research with a focus on rare diseases. Likewise, the ICON plc acquired MolecularMD laboratory in February 2019. It is a molecular diagnostic specialty laboratory that facilitates discovering, developing, and commercializing discovered medicines for cancer treatment. It aims to expand ICON's testing platforms, including next-generation sequencing and immunohistochemistry, by improving the laboratory's ability in molecular diagnostic testing.
Regional expansion to Asian countries is a strategy for global businesses to expand after the saturation of current distribution channels. Many central lab service providers in the United States are employing this strategy to draw in additional clients from adjacent countries and Latin America.
The Alba Campus in Livingston, Scotland, expanded its laboratory and operational capabilities starting in June 2021, according to a statement from Q2 Solutions. Alba Camus is a premier global provider of clinical trial services for pharmaceutical laboratories and supports new growth areas for biopharma and pharma clients globally. Besides being a wholly owned subsidiary of IQVIA, it is expanding its capabilities for genomics, flow cytometry, and translational science laboratory services.
Recent Development
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 5.8% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million or billion, Volume in Kilotons, and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization & Pricing | Available Upon Request |
The global central laboratory market value in 2023 is roughly US$ 2,543.9 million.
The global market is likely to record a 5.8% CAGR through 2033.
The global central lab market value could reach US$ 4,473.5 million by 2033.
The United States alone accounts for over 50% of the global market.
China is predicted to witness a CAGR of 7.6% through 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Service Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Service Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service Type, 2023 to 2033
5.3.1. Genetic Services
5.3.2. Biomarker Services
5.3.3. Microbiology Services
5.3.4. Anatomic Pathology/Histology
5.3.5. Specimen Management & Storage
5.3.6. Special Chemistry Services
5.3.7. Others
5.4. Y-o-Y Growth Trend Analysis By Service Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Service Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
6.3.1. Pharmaceutical Companies
6.3.2. Biotechnology Companies
6.3.3. Academic and Research Institutes
6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. South Asia and Pacific
7.3.6. East Asia
7.3.7. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Service Type
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Service Type
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Service Type
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Service Type
9.3.3. By End User
9.4. Key Takeaways
10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. UK
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Western Europe
10.2.2. By Service Type
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Service Type
10.3.3. By End User
10.4. Key Takeaways
11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Poland
11.2.1.2. Russia
11.2.1.3. Czech Republic
11.2.1.4. Romania
11.2.1.5. Rest of Eastern Europe
11.2.2. By Service Type
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Service Type
11.3.3. By End User
11.4. Key Takeaways
12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Bangladesh
12.2.1.3. Australia
12.2.1.4. New Zealand
12.2.1.5. Rest of South Asia and Pacific
12.2.2. By Service Type
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Service Type
12.3.3. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Service Type
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Service Type
13.3.3. By End User
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Service Type
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Service Type
14.3.3. By End User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Service Type
15.1.2.2. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Service Type
15.2.2.2. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Service Type
15.3.2.2. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Service Type
15.4.2.2. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Service Type
15.5.2.2. By End User
15.6. UK
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Service Type
15.6.2.2. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Service Type
15.7.2.2. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Service Type
15.8.2.2. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Service Type
15.9.2.2. By End User
15.10. Poland
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Service Type
15.10.2.2. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Service Type
15.11.2.2. By End User
15.12. Czech Republic
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Service Type
15.12.2.2. By End User
15.13. Romania
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Service Type
15.13.2.2. By End User
15.14. India
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Service Type
15.14.2.2. By End User
15.15. Bangladesh
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Service Type
15.15.2.2. By End User
15.16. Australia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Service Type
15.16.2.2. By End User
15.17. New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Service Type
15.17.2.2. By End User
15.18. China
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Service Type
15.18.2.2. By End User
15.19. Japan
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Service Type
15.19.2.2. By End User
15.20. South Korea
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Service Type
15.20.2.2. By End User
15.21. GCC Countries
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Service Type
15.21.2.2. By End User
15.22. South Africa
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2022
15.22.2.1. By Service Type
15.22.2.2. By End User
15.23. Israel
15.23.1. Pricing Analysis
15.23.2. Market Share Analysis, 2022
15.23.2.1. By Service Type
15.23.2.2. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Service Type
16.3.3. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Covance(Labcorp)
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Eurofins Global Central Library
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. PPD Central Lab
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. ICON Central Labs
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Medpace Reference Laboratory
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Q² Solutions
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Barc Lab
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Frontage Labs
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. ACM Global Laboratories
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Celerion
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Central Lab Market
